Call Us: (513) 621-5112

 
 
 
 
 
 
Sterling Research Blog
 
Contrave Approved by the FDA for Weight Loss
Friday, September 12, 2014

These are exciting days in the world of Clinical Research. On September 10th Contrave, a medication we are actively studying at Sterling Research, was approved by the FDA for weight loss. It is always satisfying when a study medication makes it to the market. Now, millions of people may benefit from Contrave. This accomplishment would not have been attained without the help of study volunteers. I commend all of the Medical Heroes that participate in Clinical Trials!

-Dr. Wenker




 
 
Subscribe To Our Blog

Blog Categories

  • Articles
  • News
    • 06/09/2017 - Understanding Fatty Liver
    • 03/28/2016 - Acne: More Than Just Pimples
    • 08/11/2015 - It's Coming...You Know It Is..
    • 02/10/2015 - Attorney General's Office Dema
    • 10/16/2014 - Regeneron, Sanofi drug slashes
    • 10/10/2014 - Ongoing Ebola Epidemic
    • 09/12/2014 - Contrave Approved by the FDA f
    • 07/11/2014 - Saxenda Recommended for Approv
    • 09/04/2013 - Only Half of Hypertensive Adul

Tag Cloud
 
 
 

CONTACT US
NEWS & ARTICLES
Call For Participation
Patient Recruitment Specialist
Cincinnati, OH

PH: (513) 621-5112
FX:  (513) 621-5101

Cincinnati / Mt. Auburn
2230 Auburn Avenue
Level B
Cincinnati, OH 45219
PH: (513) 381-4100
FX:  (513) 381-4120

Springdale
375 Glensprings Drive
2nd Floor
Cincinnati, OH 45246
PH: (513) 671-8080
FX:  (513) 671-8090
C-Diff: Could a vaccine prevent this contagious killer?
Tuesday, July 11, 2017

Clostridium difficile (C-diff) is a bacterial infection that causes abdominal pain, fever and diarrhea. The symptoms may range from mild to severe and can lead to death.

 
 
 



Copyright © 2017. STERLING RESEARCH. All Rights Reserved